Dianthus Therapeutics, Inc. revenue breakdown overview

Dianthus Therapeutics, Inc. revenue for the last year amounted to 6.24 M USD, the most of which — 6.24 M USD — came from its highest performing source at the moment, Complement Therapeutics, the year earlier bringing 2.83 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Dianthus Therapeutics, Inc. 6.24 M USD, and the year before that — 2.83 M USD.